CTRI/2021/07/035256尚未招募3 期
Effect of nintedanib in the prognosis of young and middle aged COVID 19 patients
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- Self
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Without any comorbidities
排除标准
- •Diabetes, hypertension, IHD, CKD, immunosuppressive status, old age
研究者
相似试验
招募中
不适用
Efficacy and safety of nintedanib for progressive fibrosing interstitial diseases in single center cohort studyJPRN-UMIN000042254Japanese Red Cross Medical Center40
招募中
不适用
The safety and efficacy of nintedanib for patients with progressive fibrosing interstitial lung disease in a real world setting-a prospective observational studyProgressive fibrosing interstitial lung diseaseJPRN-UMIN000041380Department of Respiratory Medicine, Juntendo University Hospital300
进行中（未招募）
1 期
iCCC - A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or EndometriumRecurrent clear cell carcinoma of the ovary or endometriumMedDRA version: 21.1Level: PTClassification code 10009252Term: Clear cell endometrial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-002109-73-NLEuropean Organisation for Research and Treatment of Cancer120
进行中（未招募）
1 期
iCCC - A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or EndometriumRecurrent clear cell carcinoma of the ovary or endometriumMedDRA version: 19.0Level: PTClassification code 10009252Term: Clear cell endometrial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-002109-73-FRGreater Glasgow Health Board120
进行中（未招募）
1 期
iCCC - A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or EndometriumEUCTR2013-002109-73-FIGreater Glasgow Health Board120